Apheresis Market - Future Trends to Boost the Global Revenue Growth

 Recent Developments in the Global Apheresis Market:

# In July 2019, Baxter International Inc. (US) launched the PrisMax system in the US.

# In June 2019, Toray Medical Co. Ltd. (Japan) launched the TORAMYXIN device in the European region.

# In October 2019, Terumo BCT (US) collaborated with the UniCAR-Therapy Bio-Medicine Technology Co. (China). This collaboration aimed at advancing CAR T-cell therapies by creating a new Shanghai Center of Excellence. This development also helped Terumo widen its applications of apheresis and leukapheresis procedures.

# In August 2017, Fresenius Medical Care (Germany) acquired NxStage Medical, Inc. (US). This acquisition enabled Fresenius Medical Care to further expand its presence in the renal care and critical care area.

Global Growth Driving Factors:

The market for apheresis is primarily driven by the rising prevalence of chronic diseases and the growing number of trauma and injury cases, the increasing demand for source plasma from biopharmaceutical companies, the rising demand for blood components and growing concerns regarding blood safety, the increase in the number of complex surgical procedures, and the favorable reimbursement for apheresis procedures.

However, the high cost of apheresis devices & therapeutic apheresis procedures and installation of apheresis devices through the rental model, fewer blood donations using apheresis due to lack of awareness, and the stringent donor recruitment criteria are factors expected to limit market growth to a certain extent in the coming years.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=950

Expected Revenue Growth:

The global apheresis market is expected to reach USD 2.7 billion by 2025 from an estimated value of USD 1.7 billion in 2019, growing at a CAGR of 8.1% during the forecast period.

The photopheresis segment is projected to grow at the highest CAGR during the forecast period

On the basis of application, the apheresis market is segmented into plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis, photopheresis, and other applications. The photopheresis segment is expected to grow at the highest rate during the forecast period. Growth in this segment can be attributed to the increasing prevalence of blood disorders and the rising demand for photopheresis in organ transplant rejection treatments.

In 2018, the blood collection centers and blood component providers segment accounted for the largest share of the market

Based on end users, the apheresis market is segmented into blood collection centers and blood component providers, hospitals and transfusion centers, and other end users. In 2018, the blood collection centers and blood component providers segment accounted for the largest share of 67.5% of the global apheresis market. The large share of this end-user segment is mainly attributed to the rising number of blood component donations, a growing number of blood centers, and increasing awareness of blood collection.

Geographical Growth:

North America accounted for the largest share of the apheresis market in 2018

The apheresis market is segmented into five major regions, namely, North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest share of the apheresis market. The large share of this region can be attributed to easier access to advanced blood collection technologies, the presence of established healthcare infrastructure, and the increasing presence of leading apheresis companies in the country.

Key Market Players

The key players in the global apheresis market are Terumo BCT, Inc. (US), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Asahi Kasei Medical Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Cerus Corporation (US), Kaneka Corporation (Japan), Kawasumi Laboratories, Inc. (Japan), and Nikkiso Co., Ltd. (Japan).

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=950

Critical Questions Answered by this Study:

# Where will these developments take the industry in the mid-to-long term?
# Who are the major end users in the apheresis market, and what are the benefits they avail by implementing apheresis technology?
# What are the recent trends in the apheresis market?
# What are the major market dynamics and their impact on overall market growth?
# What is the global scenario of the apheresis market?

Global Apheresis Market is Expecting Major Revenue Surge by 2025

 Major Growth Influencing Factors:

The rising prevalence of chronic diseases and the growing number of trauma & injury cases, the rising demand for blood components and growing concerns regarding blood safety, and the favorable reimbursement for apheresis procedures are the major factors driving the growth of apheresis market.

Projected Revenue Surge During the Forecast Period:

The global apheresis market is projected to reach USD 2.7 billion by 2025 from USD 1.7 billion in 2019, at a CAGR of 8.1% during the forecast period.

The photopheresis segment is expected to grow at the highest CAGR during the forecast period

Based on application, the apheresis market is segmented into plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis, photopheresis, and other applications. The photopheresis is expected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the increasing prevalence of blood disorders and the rising demand for photopheresis in organ transplant rejection treatment.

The disposables segment is expected to grow at the highest CAGR during the forecast period

Based on products, the apheresis market is segmented into devices and disposables. The disposable segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to its recurrent use, increasing blood donations using apheresis devices, an increasing number of therapeutic apheresis procedures, and favorable reimbursement policies for apheresis procedures.

The centrifugation technology segment is expected to grow at the highest CAGR during the forecast period

Based on technology, the apheresis market is segmented into centrifugation technology and membrane separation technology. The centrifugation segment is expected to grow at the highest CAGR during the forecast period. This high growth can be attributed to the advantages offered by centrifugation over membrane separation, such as its high efficiency and its ability to separate all types of blood components

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=950

The hospitals and transfusion centers segment is expected to grow at the highest CAGR during the forecast period

On the basis of end user, the apheresis market has been segmented into blood collection centers and blood component providers, hospitals and transfusion centers, and other end users. The hospitals and transfusion centers segment is estimated to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the increasing adoption of therapeutic apheresis in the treatment of various diseases, growing indications of therapeutic apheresis, and rising awareness of apheresis as a therapy.

North America accounted for the largest market share in 2018

North America accounted for the largest share of the apheresis market in 2018, followed by Europe. The large share of this region can be attributed to easier accessibility to advanced blood collection technologies, the presence of established healthcare infrastructure, and the increasing presence of leading apheresis companies in the country.

The therapeutic apheresis segment is expected to grow at the highest CAGR during the forecast period

Based on procedure, the apheresis market is segmented into automated blood collection (donor apheresis) and therapeutic apheresis. The therapeutic apheresis segment is expected to grow at the highest CAGR during the forecast period. Growth in this segment can be attributed to the increasing adoption of apheresis procedures for the treatment of various neurological, blood, and renal diseases; the increasing prevalence of blood disorders; and favorable reimbursement policies for apheresis procedures.

Key Players:

The prominent players in this market are Terumo BCT, Inc. (US), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Asahi Kasei Medical Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Cerus Corporation (US), Kaneka Corporation (Japan), Kawasumi Laboratories, Inc. (Japan), Nikkiso Co., Ltd. (Japan), Macopharma SA (France), Miltenyi Biotec (Germany), Otsuka Holdings Co. Ltd. (Japan), Medica S.p.A. (Italy), Mallinckrodt plc (Ireland), Medicap Clinic GmbH (Germany), Lmb Technologies GmbH (Germany), Bioelettronica (Italy), Infomed (Switzerland), Cytosorbents Corporation (US), and Toray Medical Co. Ltd. (Japan), among other key players.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=950

Apheresis Market - Emerging Innovations & Global Future Forecasts

 Global Industry Growth Driving Factors:

The global apheresis market is primarily driven by the rising prevalence of chronic diseases and the growing number of trauma and injury cases, the increasing demand for source plasma from biopharmaceutical companies, the rising demand for blood components and growing concerns regarding blood safety, the increase in the number of complex surgical procedures, and the favorable reimbursement for apheresis procedures.

However, the high cost of apheresis devices & therapeutic apheresis procedures and installation of apheresis devices through the rental model, fewer blood donations using apheresis due to lack of awareness, and the stringent donor recruitment criteria are factors expected to limit market growth to a certain extent in the coming years.

Research Methodologies Followed for This Study:

Primary Research:

In the primary research process, industry experts from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. Industry experts from the supply side include CEOs, vice presidents, marketing and sales directors, product managers, business development managers, technology and innovation directors of companies providing apheresis, key opinion leaders, and suppliers and distributors. The industry experts from the demand side include hospitals, blood collection centers, transfusion clinics, and healthcare payers.

Secondary Research:

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the apheresis market.

It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=950

Recent Developments:

# In July 2019, Baxter International Inc. (US) launched the PrisMax system in the US.
# In June 2019, Toray Medical Co. Ltd. (Japan) launched the TORAMYXIN device in the European region.
# In October 2019, Terumo BCT (US) collaborated with the UniCAR-Therapy Bio-Medicine Technology Co. (China). This collaboration aimed at advancing CAR T-cell therapies by creating a new Shanghai Center of Excellence. This development also helped Terumo widen its applications of apheresis and leukapheresis procedures.
# In August 2017, Fresenius Medical Care (Germany) acquired NxStage Medical, Inc. (US). This acquisition enabled Fresenius Medical Care to further expand its presence in the renal care and critical care area.

In 2018, the blood collection centers and blood component providers segment accounted for the largest share of the market

Based on end users, the apheresis market is segmented into blood collection centers and blood component providers, hospitals and transfusion centers, and other end users. In 2018, the blood collection centers and blood component providers segment accounted for the largest share of 67.5% of the global apheresis market. The large share of this end-user segment is mainly attributed to the rising number of blood component donations, a growing number of blood centers, and increasing awareness of blood collection.

Critical Questions Answered:

# Where will these developments take the industry in the mid-to-long term?
# Who are the major end users in the apheresis market, and what are the benefits they avail by implementing apheresis technology?
# What are the recent trends in the apheresis market?
# What are the major market dynamics and their impact on overall market growth?
# What is the global scenario of the apheresis market?

North America accounted for the largest share of the apheresis market in 2018

The apheresis market is segmented into five major regions, namely, North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest share of the apheresis market. The large share of this region can be attributed to easier access to advanced blood collection technologies, the presence of established healthcare infrastructure, and the increasing presence of leading apheresis companies in the country.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=950

Global Apheresis Market to Grow Worth $2.7 billion by 2025

 Global Growth Driving Factors:

The rising prevalence of chronic diseases and the growing number of trauma & injury cases, the rising demand for blood components and growing concerns regarding blood safety, and the favorable reimbursement for apheresis procedures are the major factors driving the growth of apheresis market.

Projected Revenue Surge:

The global apheresis market is projected to reach USD 2.7 billion by 2025 from USD 1.7 billion in 2019, at a CAGR of 8.1% during the forecast period.

The centrifugation technology segment is expected to grow at the highest CAGR during the forecast period

Based on technology, the apheresis market is segmented into centrifugation technology and membrane separation technology. The centrifugation segment is expected to grow at the highest CAGR during the forecast period. This high growth can be attributed to the advantages offered by centrifugation over membrane separation, such as its high efficiency and its ability to separate all types of blood components

The photopheresis segment is expected to grow at the highest CAGR during the forecast period

Based on application, the apheresis market is segmented into plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis, photopheresis, and other applications. The photopheresis is expected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the increasing prevalence of blood disorders and the rising demand for photopheresis in organ transplant rejection treatment.

The disposables segment is expected to grow at the highest CAGR during the forecast period

Based on products, the apheresis market is segmented into devices and disposables. The disposable segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to its recurrent use, increasing blood donations using apheresis devices, an increasing number of therapeutic apheresis procedures, and favorable reimbursement policies for apheresis procedures.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=950

The therapeutic apheresis segment is expected to grow at the highest CAGR during the forecast period

Based on procedure, the apheresis market is segmented into automated blood collection (donor apheresis) and therapeutic apheresis. The therapeutic apheresis segment is expected to grow at the highest CAGR during the forecast period. Growth in this segment can be attributed to the increasing adoption of apheresis procedures for the treatment of various neurological, blood, and renal diseases; the increasing prevalence of blood disorders; and favorable reimbursement policies for apheresis procedures.

The hospitals and transfusion centers segment is expected to grow at the highest CAGR during the forecast period

On the basis of end user, the apheresis market has been segmented into blood collection centers and blood component providers, hospitals and transfusion centers, and other end users. The hospitals and transfusion centers segment is estimated to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the increasing adoption of therapeutic apheresis in the treatment of various diseases, growing indications of therapeutic apheresis, and rising awareness of apheresis as a therapy.

North America accounted for the largest market share in 2018

North America accounted for the largest share of the apheresis market in 2018, followed by Europe. The large share of this region can be attributed to easier accessibility to advanced blood collection technologies, the presence of established healthcare infrastructure, and the increasing presence of leading apheresis companies in the country.

Key Players:

The prominent players in this market are Terumo BCT, Inc. (US), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Asahi Kasei Medical Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Cerus Corporation (US), Kaneka Corporation (Japan), Kawasumi Laboratories, Inc. (Japan), Nikkiso Co., Ltd. (Japan), Macopharma SA (France), Miltenyi Biotec (Germany), Otsuka Holdings Co. Ltd. (Japan), Medica S.p.A. (Italy), Mallinckrodt plc (Ireland), Medicap Clinic GmbH (Germany), Lmb Technologies GmbH (Germany), Bioelettronica (Italy), Infomed (Switzerland), Cytosorbents Corporation (US), and Toray Medical Co. Ltd. (Japan), among other key players.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=950

Apheresis Market - Major Revenue Surge is Projected in the Near Future

Major Growth Boosting Factors:

The apheresis market is primarily driven by the rising prevalence of chronic diseases and the growing number of trauma and injury cases, the increasing demand for source plasma from biopharmaceutical companies, the rising demand for blood components and growing concerns regarding blood safety, the increase in the number of complex surgical procedures, and the favorable reimbursement for apheresis procedures.

However, the high cost of apheresis devices & therapeutic apheresis procedures and installation of apheresis devices through the rental model, fewer blood donations using apheresis due to lack of awareness, and the stringent donor recruitment criteria are factors expected to limit market growth to a certain extent in the coming years.

Expected Revenue Surge Globally:

The global apheresis market is expected to reach USD 2.7 billion by 2025 from an estimated value of USD 1.7 billion in 2019, growing at a CAGR of 8.1% during the forecast period.

Recent Developments:

# In July 2019, Baxter International Inc. (US) launched the PrisMax system in the US.

# In June 2019, Toray Medical Co. Ltd. (Japan) launched the TORAMYXIN device in the European region.

# In October 2019, Terumo BCT (US) collaborated with the UniCAR-Therapy Bio-Medicine Technology Co. (China). This collaboration aimed at advancing CAR T-cell therapies by creating a new Shanghai Center of Excellence. This development also helped Terumo widen its applications of apheresis and leukapheresis procedures.

# In August 2017, Fresenius Medical Care (Germany) acquired NxStage Medical, Inc. (US). This acquisition enabled Fresenius Medical Care to further expand its presence in the renal care and critical care area.

The centrifugal apheresis devices segment is projected to grow at the highest CAGR during the forecast period

 Based on the type of apheresis devices, the market is segmented into centrifugal apheresis devices and membrane separation devices. The centrifugal apheresis devices segment is expected to grow at the highest rate during the forecast period. Factors such as advantages offered by centrifugation over membrane separation and the higher efficiency of centrifugation with the ability to separate all types of blood components are propelling the growth of the centrifugal apheresis devices market.

Request Sample Pages@ 

https://www.marketsandmarkets.com/requestsampleNew.asp?id=950

The therapeutic apheresis segment is projected to grow at the highest CAGR during the forecast period

On the basis of procedure, the apheresis market is segmented into automated blood collection (donor apheresis) and therapeutic apheresis. The therapeutic apheresis segment is expected to grow at the highest rate during the forecast period. Growth in this segment can be attributed to the increasing adoption of apheresis procedures for the treatment of various neurological, blood, and renal diseases, the increasing prevalence of blood disorders, and favorable reimbursement policies for apheresis procedures.

The photopheresis segment is projected to grow at the highest CAGR during the forecast period

On the basis of application, the apheresis market is segmented into plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis, photopheresis, and other applications. The photopheresis segment is expected to grow at the highest rate during the forecast period. Growth in this segment can be attributed to the increasing prevalence of blood disorders and the rising demand for photopheresis in organ transplant rejection treatments.

Key Players:

The key players in the global apheresis market are Terumo BCT, Inc. (US), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Asahi Kasei Medical Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Cerus Corporation (US), Kaneka Corporation (Japan), Kawasumi Laboratories, Inc. (Japan), and Nikkiso Co., Ltd. (Japan).

In 2018, the blood collection centers and blood component providers segment accounted for the largest share of the market

Based on end users, the apheresis market is segmented into blood collection centers and blood component providers, hospitals and transfusion centers, and other end users. In 2018, the blood collection centers and blood component providers segment accounted for the largest share of 67.5% of the global apheresis market. The large share of this end-user segment is mainly attributed to the rising number of blood component donations, a growing number of blood centers, and increasing awareness of blood collection.

North America accounted for the largest share of the apheresis market in 2018

The apheresis market is segmented into five major regions, namely, North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest share of the apheresis market. The large share of this region can be attributed to easier access to advanced blood collection technologies, the presence of established healthcare infrastructure, and the increasing presence of leading apheresis companies in the country.

Download PDF Brochure@ 

https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=950

Apheresis Market - Projected Revenue Surge by 2025

 Expected Revenue Surge:

The global apheresis market is projected to reach USD 2.7 billion by 2025 from USD 1.7 billion in 2019, at a CAGR of 8.1% during the forecast period.

Major Growth Boosting Factors:

The rising prevalence of chronic diseases and the growing number of trauma & injury cases, the rising demand for blood components and growing concerns regarding blood safety, and the favorable reimbursement for apheresis procedures are the major factors driving the growth of this market.

The disposables segment is expected to grow at the highest CAGR during the forecast period

Based on products, the apheresis market is segmented into devices and disposables. The disposable segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to its recurrent use, increasing blood donations using apheresis devices, an increasing number of therapeutic apheresis procedures, and favorable reimbursement policies for apheresis procedures.

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=950

The therapeutic apheresis segment is expected to grow at the highest CAGR during the forecast period

Based on procedure, the apheresis market is segmented into automated blood collection (donor apheresis) and therapeutic apheresis. The therapeutic apheresis segment is expected to grow at the highest CAGR during the forecast period. Growth in this segment can be attributed to the increasing adoption of apheresis procedures for the treatment of various neurological, blood, and renal diseases; the increasing prevalence of blood disorders; and favorable reimbursement policies for apheresis procedures.

The centrifugation technology segment is expected to grow at the highest CAGR during the forecast period

Based on technology, the apheresis market is segmented into centrifugation technology and membrane separation technology. The centrifugation segment is expected to grow at the highest CAGR during the forecast period. This high growth can be attributed to the advantages offered by centrifugation over membrane separation, such as its high efficiency and its ability to separate all types of blood components

The photopheresis segment is expected to grow at the highest CAGR during the forecast period

Based on application, the apheresis market is segmented into plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis, photopheresis, and other applications. The photopheresis is expected to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the increasing prevalence of blood disorders and the rising demand for photopheresis in organ transplant rejection treatment.

The hospitals and transfusion centers segment is expected to grow at the highest CAGR during the forecast period

On the basis of end user, the apheresis market has been segmented into blood collection centers and blood component providers, hospitals and transfusion centers, and other end users. The hospitals and transfusion centers segment is estimated to grow at the highest CAGR during the forecast period. The high growth of this segment can be attributed to the increasing adoption of therapeutic apheresis in the treatment of various diseases, growing indications of therapeutic apheresis, and rising awareness of apheresis as a therapy.

North America accounted for the largest market share in 2018

North America accounted for the largest share of the apheresis market in 2018, followed by Europe. The large share of this region can be attributed to easier accessibility to advanced blood collection technologies, the presence of established healthcare infrastructure, and the increasing presence of leading apheresis companies in the country.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=950

Global Key Players:

The prominent players in this market are Terumo BCT, Inc. (US), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Asahi Kasei Medical Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Cerus Corporation (US), Kaneka Corporation (Japan), Kawasumi Laboratories, Inc. (Japan), Nikkiso Co., Ltd. (Japan), Macopharma SA (France), Miltenyi Biotec (Germany), Otsuka Holdings Co. Ltd. (Japan), Medica S.p.A. (Italy), Mallinckrodt plc (Ireland), Medicap Clinic GmbH (Germany), Lmb Technologies GmbH (Germany), Bioelettronica (Italy), Infomed (Switzerland), Cytosorbents Corporation (US), and Toray Medical Co. Ltd. (Japan), among other key players.

Apheresis Market worth $2.7 billion by 2025

 Overview:

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, key market dynamics, and key player strategies.

Expected Growth in Revenue Generation:

The global apheresis market is expected to reach USD 2.7 billion by 2025 from an estimated value of USD 1.7 billion in 2019, growing at a CAGR of 8.1% during the forecast period. 

Download PDF Brochure@ 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=950

Global Growth Influencing Factors:

The market for apheresis is primarily driven by the rising prevalence of chronic diseases and the growing number of trauma and injury cases, the increasing demand for source plasma from biopharmaceutical companies, the rising demand for blood components and growing concerns regarding blood safety, the increase in the number of complex surgical procedures, and the favorable reimbursement for apheresis procedures.

However, the high cost of apheresis devices & therapeutic apheresis procedures and installation of apheresis devices through the rental model, fewer blood donations using apheresis due to lack of awareness, and the stringent donor recruitment criteria are factors expected to limit market growth to a certain extent in the coming years.

The centrifugal apheresis devices segment is projected to grow at the highest CAGR during the forecast period

Based on the type of apheresis devices, the market is segmented into centrifugal apheresis devices and membrane separation devices. The centrifugal apheresis devices segment is expected to grow at the highest rate during the forecast period. Factors such as advantages offered by centrifugation over membrane separation and the higher efficiency of centrifugation with the ability to separate all types of blood components are propelling the growth of the centrifugal apheresis devices market.

The therapeutic apheresis segment is projected to grow at the highest CAGR during the forecast period

On the basis of procedure, the apheresis market is segmented into automated blood collection (donor apheresis) and therapeutic apheresis. The therapeutic apheresis segment is expected to grow at the highest rate during the forecast period. Growth in this segment can be attributed to the increasing adoption of apheresis procedures for the treatment of various neurological, blood, and renal diseases, the increasing prevalence of blood disorders, and favorable reimbursement policies for apheresis procedures.

The photopheresis segment is projected to grow at the highest CAGR during the forecast period

On the basis of application, the apheresis market is segmented into plasmapheresis, plateletpheresis, erythrocytapheresis, leukapheresis, photopheresis, and other applications. The photopheresis segment is expected to grow at the highest rate during the forecast period. Growth in this segment can be attributed to the increasing prevalence of blood disorders and the rising demand for photopheresis in organ transplant rejection treatments.

In 2018, the blood collection centers and blood component providers segment accounted for the largest share of the market

Based on end users, the apheresis market is segmented into blood collection centers and blood component providers, hospitals and transfusion centers, and other end users. In 2018, the blood collection centers and blood component providers segment accounted for the largest share of 67.5% of the global apheresis market. The large share of this end-user segment is mainly attributed to the rising number of blood component donations, a growing number of blood centers, and increasing awareness of blood collection.

Request Sample Pages@ 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=950

North America accounted for the largest share of the apheresis market in 2018

The apheresis market is segmented into five major regions, namely, North America, Europe, the Asia Pacific (APAC), Latin America, and the Middle East & Africa. In 2018, North America accounted for the largest share of the apheresis market. The large share of this region can be attributed to easier access to advanced blood collection technologies, the presence of established healthcare infrastructure, and the increasing presence of leading apheresis companies in the country.

Key Market Players

The key players in the global apheresis market are Terumo BCT, Inc. (US), Fresenius SE & Co. KGaA (Germany), Haemonetics Corporation (US), Asahi Kasei Medical Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Cerus Corporation (US), Kaneka Corporation (Japan), Kawasumi Laboratories, Inc. (Japan), and Nikkiso Co., Ltd. (Japan).

Read More Detailed Report@ 
https://www.marketsandmarkets.com/Market-Reports/apheresis-market-950.html